InsidersTradesSigma
Explore the full record of transactions filed by Lee Byoung Chul, 首席执行官. Director active across 2 companies, notably 카나프테라퓨틱스. In total, 2 filings have been published. Regulator: DART (FSS). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
LEE BYOUNG CHUL is the CEO of 카나프테라퓨틱스, a company specializing in biotechnology. He is responsible for the overall strategy and product development. LEE BYOUNG CHUL is committed to positioning the company as a leader in innovative therapies.